Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Postbiotics derived from recombinant lactic acid bacteria exhibit high IL6-binding capacity and suppress IL6-induced STAT3 signaling
Avtorji:ID Zahirović, Abida, Institut "Jožef Stefan" (Avtor)
ID Zupančič, Špela (Avtor)
ID Verdir, Andraž, Institut "Jožef Stefan" (Avtor)
ID Nemec, Sebastjan, Institut "Jožef Stefan" (Avtor)
ID Kralj, Slavko, Institut "Jožef Stefan" (Avtor)
ID Snoj, Luka, Institut "Jožef Stefan" (Avtor)
ID Berlec, Aleš, Institut "Jožef Stefan" (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1657810/full
 
.pdf PDF - Predstavitvena datoteka, prenos (2,98 MB)
MD5: 235A1B5C03C3CA8ECA7BFE373E826011
 
Jezik:Angleški jezik
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:Logo IJS - Institut Jožef Stefan
Povzetek:Introduction: With growing evidence of clinical efficacy of probiotics in various diseases, safety concerns have arisen regarding the therapeutic use of live probiotic bacteria, especially in critically ill, immunocompromised, and pediatric populations. Serious probiotic-related adverse effects have been reported in these patients, including bloodstream infection and sepsis. This has led to an increased interest in developing postbiotics (non-viable bacterial products) that may exert beneficial effects on the host without the risks associated with administration of live microorganisms. The aim of this study was to explore postbiotic potential of recombinant Lactococcus lactis bacteria that have been engineered to display interleukin 6 (IL6)-targeting affibody (ZIL6) on their surface and are intended for treatment of inflammatory intestinal diseases. Methods: Five different killing treatments were applied to kill bacteria (heat, ethanol, sonication, UV, and gamma irradiation) and their effect on bacterial viability, morphology and functionality was examined in vitro using a combination of different techniques, including microscopy, flow cytometry, immunoassays and cell-based reporter assay. Results: The results showed that ZIL6 affibody displayed on L. lactis via non-covalent anchoring withstood the treatments applied to kill bacteria and remained functional after the loss of microbial viability. The degree of functionality was dependent on the type of treatment. Heat-killed cells retained 50% of the activity of live strain, while most of the activity was preserved after exposure of bacteria to ethanol, sonication, UV and gamma irradiation. The applied treatments varied in killing efficacy, whereby ethanol and heat rendered bacteria non-viable, UV and gamma irradiation yielded non-replicative cells, whereas sonication was ineffective in killing L. lactis. Among non-viable cells, ethanol-killed bacteria exhibited the greatest activity and showed high maximum binding capacity of 200 ng IL6 per mg dry cell weight, possessed strong nanomolar affinity for IL6, and inhibited up to 78% of IL6-induced STAT3 signaling. Conclusion: The study demonstrates that functional non-viable bacterial cells can be derived from the recombinant L. lactis with therapeutic proteins displayed on their surface and provides a good foundations for further studies of their postbiotic potential in adjunctive therapy of inflammatory intestinal diseases.
Ključne besede:affibody, probiotics, postbiotics, Lactococcus lactis
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:16.07.2025
Datum sprejetja članka:02.10.2025
Datum objave:24.10.2025
Založnik:Frontiers
Leto izida:2025
Št. strani:str. 1-19
Številčenje:Vol. 16
Izvor:Švica
PID:20.500.12556/DiRROS-23989 Novo okno
UDK:615
ISSN pri članku:1664-302X
DOI:10.3389/fmicb.2025.1657810 Novo okno
COBISS.SI-ID:255694595 Novo okno
Avtorske pravice:© 2025 Zahirović, Zupančič, Verdir, Nemec, Kralj, Snoj and Berlec.
Opomba:Nasl. z nasl. zasl.; Soavtorji: Špela Zupančič, Andraž Verdir, Sebastjan Nemec, Slavko Kralj, Luka Snoj, Aleš Berlec; Opis vira z dne 3. 11. 2025;
Datum objave v DiRROS:03.11.2025
Število ogledov:188
Število prenosov:98
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in microbiology
Skrajšan naslov:Front. microbiol.
Založnik:Frontiers Research Foundation
ISSN:1664-302X
COBISS.SI-ID:4146296 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:Z4-4566-2022
Naslov:Razvoj mlečnokislinskih bakterij za ciljano dostavo protitumorskih učinkovin

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P4-0127-2019
Naslov:Farmacevtska biotehnologija: znanost za zdravje

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J7-4418-2022
Naslov:Nanovlakna za sočasno dostavo koktajlov izbrane mikrobiote in protimikrobnih učinkovin za lokalno zdravljenje vaginalnih infekcij

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J2-60047-2025
Naslov:Magnetno mikrostrukturiranje površin iz Mg zlitine za izboljšano endotelizacijo in zadržano razgradljivost materialov žilnih opornic

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:24.10.2025
Vezano na:VoR

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:probiotiki, postbiotiki, Lactococcus lactis, mlečnokislinske bakterije


Nazaj